Skip to content

D44.3

Billable

Neoplasm of uncertain behavior of pituitary gland

Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)

Is D44.3 an HCC code?

Yes. D44.3 maps to Melanoma and Other Skin Cancers under the CMS-HCC V28 risk adjustment model (and Breast, Prostate, and Other Cancers and Tumors under V24).

HCC Category Mapping

V28HCC 23Melanoma and Other Skin Cancers
0.251
V24HCC 12Breast, Prostate, and Other Cancers and Tumors
0.150
ESRDHCC 12Breast, Prostate, and Other Cancers and Tumors
0.000
RxHCCHCC 22Cancer, Other Specified Sites
0.000

RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

MEAT Criteria for D44.3

For D44.3 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed D44.3 during that encounter — not just copy-forwarded from a problem list.

What This Code Means

D44.3 is the ICD-10-CM diagnosis code for neoplasm of uncertain behavior of pituitary gland. A tumor of the pituitary gland (small gland at the base of the brain) that cannot yet be classified as definitely benign or malignant. D44.3 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (d37-d48).

Under the CMS-HCC V28 risk adjustment model, D44.3 maps to Melanoma and Other Skin Cancers (HCC 23) with a community, non-dual, aged base RAF weight of 0.251. Under the older CMS-HCC V24 model, D44.3 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

Document functional status if known (hormone-secreting vs. non-functional). Because D44.3 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for D44.3 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Document functional status if known (hormone-secreting vs. non-functional)
  • Coordinate with endocrinology notes and imaging to support uncertain behavior classification

Clinical Significance

Neoplasms of uncertain behavior of the pituitary gland include atypical pituitary adenomas with features that prevent definitive benign or malignant classification. These tumors can cause significant endocrine dysfunction through hormone hypersecretion (acromegaly, Cushing disease, hyperprolactinemia) or hypopituitarism from mass effect on normal pituitary tissue.

Documentation Requirements

  • Documentation must specify the pituitary gland location, supported by sellar magnetic resonance imaging and pathology.
  • Functional status (hormone-secreting versus non-functional) should be documented along with relevant hormone levels.
  • Pathology should describe atypical features including elevated Ki-67 index, mitotic activity, or p53 expression that support uncertain behavior.

Use Additional Code

  • code to identify any functional activity.

Commonly Confused Codes

  • D35.2 (benign neoplasm of pituitary gland) is used for typical pituitary adenomas with benign behavior.
  • C75.1 (malignant neoplasm of pituitary gland) is used for pituitary carcinomas.
  • D44.4 (uncertain behavior of craniopharyngeal duct) involves a different sellar structure.
  • E22.0 (acromegaly) or E24.0 (Cushing disease) may be coded additionally for hormonal effects.

Code Hierarchy

Open D44.3 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.